perylene has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bai, M; Bao, Y; Huang, Y; Li, Y; Liang, C; Liu, L; Song, Z; Sun, L; Wang, S; Yang, H; Yi, J; Yu, C | 1 |
1 other study(ies) available for perylene and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo.
Topics: AMP-Activated Protein Kinases; Animals; Anthracenes; Apoptosis; Cell Differentiation; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Male; Mesenchymal Stem Cells; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Perylene; Reactive Oxygen Species | 2020 |